Accepted at 5:58 a.m. Jul, 23, 2025 by mohannadkh10
Author: DillingerMed
Co-authors: mohannadkh10
Related Note: 1502044346014
Rationale for change

We don't desensitize every patient, only those with certain types of syphilis (neural, pregnancy, oto, ocular, treatment failure of second-line therapies). That's covered in another card (nid:1553075655433), so I think just a brief mention of it here or even completely removing this from the card is probably ok.

Extra Extra
Text
Lecture Notes
Empty field
Missed Questions
Empty field
Pathoma
Empty field
Boards and Beyond
Empty field
First Aid
Sketchy
Sketchy 2
Sketchy Extra
Picmonic
Empty field
Pixorize
Empty field
Physeo
Empty field
Bootcamp
OME
Additional Resources
Empty field
One by one
Empty field
#AK_Step1_v12::#UWorld::COMLEX::26713 #AK_Step1_v12::#FirstAid::03_Microbiology::06_Systems::12_Sexually_transmitted_infections #AK_Step1_v12::#SketchyPharm::07_Antimicrobials::01_Cell_Wall_&_Membrane-Active_Antibiotics::01_Penicillin #AK_Step2_v12::#SketchyIM::09_Infectious_Diseases::03_GU_Infections::04_Genital_Ulcers_DDx #AK_Step1_v12::#FirstAid::03_Microbiology::02_Clinical_Bacteriology::39_Spirochetes #AK_Step1_v12::#AMBOSS::ZA0ZRi #AK_Step2_v12::#AMBOSS::fi0kIf #AK_Step2_v12::#Bootcamp::Pediatrics::01_Neonatology::05_Teratogen_and_TORCH::04_Congenital_TORCH_Infections_II #AK_Step2_v12::#UWorld::COMLEX::103642 #AK_Step1_v12::#Bootcamp::Microbiology::36_Antibiotics::03_Classic_Penicillins #AK_Step1_v12::#FirstAid::03_Microbiology::02_Clinical_Bacteriology::42_Syphilis #AK_Step1_v12::#NBME::21 #AK_Other::#AK_Original_Decks::Step_1::Lolnotacop::Bugs #PANCE::INFECTIOUS_DISEASE::perinatal_transmission_of_disorders #AK_Step2_v12::#AMBOSS::eDaxW5 #AK_Step2_v12::#UWorld::Step::16921 #PANCE::EOR::PEDS #AK_Step2_v12::#B&B::11_Obstetrics_and_Gynecology::01_Obstetrics::06_TORCH_Infections #AK_Step3_v12::#UWorld::6130 #AK_Step1_v12::#SketchyMicro::01_Bacteria::09_Spirochetes::03_Treponema_pallidum #AK_Step1_v12::#Bootcamp::Microbiology::15_Spirochetes::04_Treponemal_Diagnostics_and_Management #AK_Step2_v12::#B&B::08_Infectious_Disease::04_Other::02_Sexually-transmitted_Infections #AK_Step1_v12::#OME::03_Immune::01_Microbiology::01_Bacteria::11_Gram_Negative_Rods_Spirochetes #AK_Step1_v12::#AMBOSS::3kaSnk #AK_Step1_v12::#Low/HighYield::1-HighYield #AK_Step1_v12::#OME::PreClinical::03_Immune::01_Microbiology::01_Bacteria::11_Gram_Negative_Rods_Spirochetes #AK_Step1_v12::#UWorld::Step::18620 #AK_Step1_v12::#Physeo::06_Micro::02_Bacteria::46_Treponema_Pallidum #AK_Step2_v12::#AMBOSS::ui0ptf #AK_Step1_v12::#NinjaNerd::03_Microbiology::04_Pharmacology::04_Antibiotics_(Cell_Wall_Synthesis_Inhibitors:_Part_1) #AK_Step2_v12::#SketchyNeurology::08_CNS_Infections::03_Other_Infectious_Causes::04_Neurosyphilis